We are grateful for the following collaborators who have contributed source material to the EQAPOL Viral Diversity Program:
- Blood Systems Research Institute: Michael Busch, MD, PhD, Mars Stone, PhD and Sheila Keating, PhD
- Aga Khan University and Bridge Consultants Foundation: Rumina Hasan and Sharaf Ali
- Cureline, Inc.: Harminder Singh
- Harvard University: Vladimir Novitsky
- Nagoya Medical Center: Wataru Sugiura
- HIV Vaccine Trial Network (HVTN)
- American Red Cross: Susan Stramer, PhD
- South African National Blood Service: Marion Vermeulen
- Institut National de la Transfusion Sanguine: Syria Laperche, MD
- US Military HIV Research Program (MHRP), Henry M. Jackson Foundation: Mark Manak, PhD
- German Red Cross Institute Baden-Württemberg – Hessen: Michael Schmidt
- University of Sao Paulo: Ester Cerdeira Sabino, MD, PhD
- Japanese Red Cross: Kenji Tadokoro, MD
- Food and Drug Administration, Center for Biologics Evaluation and Research:Indira K. Hewlett, PhD and Viswanath Ragupathy, PhD
- Instituto de Salud Carlos III: Lucía Pérez-Álvarez, Elena Delgado, Michael Thomson, Aurora Fernández-García and Teresa Cuevas
- First Affiliated Hospital of China Medical University: Hong Shang, Wenqing Geng, Hualu Cui, and Hong Sun
- International AIDS Vaccine Initiative (IAVI): Pat Fast, MD, PhD, Jill Gilmour, BSc, PhD, Matt Price, PhD and Protocol C investigators
- University of Pennsylvania: George Shaw, MD, PhD, Beatrice Hahn, MD
- The Fraunhofer Institute for Biomedical Engineering IBMT: Hagen von Briesen, PhD
- University of Alabama at Birmingham: Joshua Baalwa
- National AIDS Research Institute, India: Ramesh Paranjape, PhD and Smita Kulkarni, PhD
- Duke Human Vaccine Institute: David Montefiori, PhD
- Center for HIV-AIDs Vaccine Immunology: Barton Haynes, MD